Evidence map›Paper›PMID 39055214›Full record

ArticleFood science & nutrition2024

Mulberry and

An-Qi Zhu, Nin Luo, Ling-Yue Sun, Xiao-Ting Zhou, Shi-Sheng Chen, Zebo Huang, Xin-Liang Mao, Kun-Ping Li

Abstract read
In one paragraph

Article in Food science & nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Phytochemical Analysis of the Extract from Berries ofInternational journal of molecular sciences · 2025
    Article
  2. Mulberry andFood science & nutrition · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

An-Qi ZhuInstitute of Chinese Medicinal Sciences Guangdong Pharmaceutical University Guangzhou China.
Nin LuoInstitute of Chinese Medicinal Sciences Guangdong Pharmaceutical University Guangzhou China.
Ling-Yue SunInstitute of Chinese Medicinal Sciences Guangdong Pharmaceutical University Guangzhou China.
Xiao-Ting ZhouInstitute of Chinese Medicinal Sciences Guangdong Pharmaceutical University Guangzhou China.
Shi-Sheng ChenPerfect Life & Health Institute Zhongshan Guangdong China.
Zebo HuangSchool of Food Science and Engineering South China University of Technology Guangzhou China.
Xin-Liang MaoPerfect Life & Health Institute Zhongshan Guangdong China.
Kun-Ping LiInstitute of Chinese Medicinal Sciences Guangdong Pharmaceutical University Guangzhou China.ORCID https://orcid.org/0000-0003-2364-8988

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyslipidemia and hepatic steatosis are the characteristics of the initial stage of nonalcohol fatty liver disease (NAFLD), which can be reversed by lifestyle intervention, including dietary supplementation. However, such commercial dietary supplements with solid scientific evidence and in particular clear mechanistic elucidation are scarce. Here, the health benefits of MHP, a commercial mulberry and

Indexed as

gene set enrichment analysishepatic steatosishyperlipidemialiver–adipose axismulberry leaf

Identifiers

PMID39055214
PMCPMC11266884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.